Silvia Chiellino

602 total citations
17 papers, 205 citations indexed

About

Silvia Chiellino is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Silvia Chiellino has authored 17 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Silvia Chiellino's work include Cutaneous Melanoma Detection and Management (5 papers), Renal cell carcinoma treatment (4 papers) and Melanoma and MAPK Pathways (3 papers). Silvia Chiellino is often cited by papers focused on Cutaneous Melanoma Detection and Management (5 papers), Renal cell carcinoma treatment (4 papers) and Melanoma and MAPK Pathways (3 papers). Silvia Chiellino collaborates with scholars based in Italy, Netherlands and United States. Silvia Chiellino's co-authors include Alessandro Testori, Alexander C. J. van Akkooi, Domenico Ciliberto, Pierfrancesco Tassone, Nicoletta Staropoli, Cirino Botta, Pierosandro Tagliaferri, Alessandra Ferrari, Catherine Klersy and Silvia Brugnatelli and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and Oncotarget.

In The Last Decade

Silvia Chiellino

14 papers receiving 202 citations

Peers

Silvia Chiellino

ONCOL

PRM

PHYSI

SURGE

Maria Grazia Vitale Italy

Maria Grazia Rodriquenz Italy

Ronan Ryan Ireland

Radhika Kainthla United States

Fumimasa Kitamura Japan

Ana María Gómez Spain

Yuqing Miao China

Alejandra Zevallos Peru

Santo Colosimo Italy

Xue-Chun Lu China

Maria Grazia Vitale Italy

Silvia Chiellino

94 ×0.9

ONCOL

57 ×0.9

65 ×1.1

PRM

45 ×0.8

PHYSI

20 ×0.7

SURGE

Citations per year, relative to Silvia Chiellino Silvia Chiellino (= 1×) peers Maria Grazia Vitale

Countries citing papers authored by Silvia Chiellino

Since Specialization

Citations

This map shows the geographic impact of Silvia Chiellino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Chiellino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Chiellino more than expected).

Fields of papers citing papers by Silvia Chiellino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Chiellino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Chiellino. The network helps show where Silvia Chiellino may publish in the future.

Co-authorship network of co-authors of Silvia Chiellino

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Chiellino. A scholar is included among the top collaborators of Silvia Chiellino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Chiellino. Silvia Chiellino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Montagna, Benedetta, et al.. (2025). Novel androgen receptor inhibitors in prostate cancer: What do we know so far?. Critical Reviews in Oncology/Hematology. 215. 104857–104857.

Barcellini, Amelia, Giulia Fontana, Giovanni Aletti, et al.. (2024). Investigating the Local Effectiveness of Carbon Ion Radiotherapy for Unresectable Female Genital Tract Melanomas: A Preliminary Real-World Study. Cancers. 16(24). 4147–4147. 3 indexed citations

Rizzo, Mimma, Silvia Chiellino, Angela Gernone, & Camillo Porta. (2022). Cisplatin-based chemotherapy for the treatment of metastatic collecting duct carcinomas: A real-world, retrospective analysis. Frontiers in Oncology. 12. 939953–939953. 5 indexed citations

Serra, Francesco, et al.. (2021). Treatment Following Progression in Metastatic Melanoma: the State of the Art from Scientific Literature to Clinical Need. Current Oncology Reports. 23(7). 84–84. 5 indexed citations

Serra, Francesco, Angioletta Lasagna, Stefania Barruscotti, et al.. (2021). Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma. Drugs in Context. 10. 1–6. 1 indexed citations

Lasagna, Angioletta, Simona Secondino, Francesco Agustoni, et al.. (2021). THE RESILIENCE OF ONCOLOGISTS DURING THE EARLY TIME OF THE COVID-19 PANDEMIC. 1(1). 56–56.

Testori, Alessandro, Silvia Chiellino, & Alexander C. J. van Akkooi. (2020). Adjuvant Therapy for Melanoma: Past, Current, and Future Developments. Cancers. 12(7). 1994–1994. 24 indexed citations

Rebuzzi, Sara Elena, Francesco Atzori, Marilena Di Napoli, et al.. (2020). Baseline and early change of systemic inflammation index (bSII and ΔSII) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with Nivolumab: Final results of the Meet-URO 15 (I-BIO-REC) study.. Journal of Clinical Oncology. 38(15_suppl). 5072–5072. 1 indexed citations

Barruscotti, Stefania, Valeria Brazzelli, Camilla Vassallo, et al.. (2020). A significant reduction in the diagnosis of melanoma during the COVID‐19 lockdown in a third‐level center in the Northern Italy. Dermatologic Therapy. 33(6). 14 indexed citations

10.

Cereda, Emanuele, Annalisa Turri, Catherine Klersy, et al.. (2019). Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy. Cancer Medicine. 8(16). 6923–6932. 77 indexed citations

11.

Cereda, Emanuele, Annalisa Turri, Catherine Klersy, et al.. (2019). CN01: Whey Protein Isolate Supplementation Improves Body Composition, Muscle Strength and Treatment Tolerance in Malnourished Advanced Cancer Patients Undergoing Chemotherapy. Clinical Nutrition. 38. S1–S1.

12.

Ciliberto, Domenico, Nicoletta Staropoli, Silvia Chiellino, et al.. (2018). The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis. Critical Reviews in Oncology/Hematology. 125. 69–77. 13 indexed citations

13.

Mantovani, Stefania, Barbara Oliviero, Dalila Mele, et al.. (2018). Defective NKp30-mediated function in hepatocellular carcinoma-infiltrating NK cells. Journal of Hepatology. 68. S679–S680. 2 indexed citations

14.

Porta, Camillo, et al.. (2017). Pharmacotherapy for treating metastatic clear cell renal cell carcinoma. Expert Opinion on Pharmacotherapy. 18(2). 205–216. 6 indexed citations

15.

Ciliberto, Domenico, Nicoletta Staropoli, Silvia Chiellino, et al.. (2016). Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer. Pancreatology. 16(2). 249–258. 17 indexed citations

16.

Staropoli, Nicoletta, Domenico Ciliberto, Silvia Chiellino, et al.. (2016). Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigation. Oncotarget. 7(50). 82741–82756. 9 indexed citations

17.

Ciliberto, Domenico, Nicoletta Staropoli, S Gualtieri, et al.. (2015). A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?. Cancer Biology & Therapy. 16(8). 1148–1159. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact